Protein lovers beware: High protein diet linked to fatty arteries

Publicly released:
International
CC:0
CC:0

A high protein diet has been linked to atherosclerosis - the build-up of fats, cholesterol and other substances in and on the artery walls - in mice by Canadian and US researchers, who also experimented with high protein diets in humans. The experiment on mice involved giving the critters either a low, moderate or high protein diet, which the researchers say had a artery thickening effect in the high protein test. The team say that increased levels of the amino acid leucine, which comes with a high protein diet, likely caused male mice to develop atherosclerosis, even in the absence of the high protein diet. In humans, the researchers found protein in excess of 25 grams per meal increases levels of leucine in our bodies and as a result may contribute to the fatty arteries.

News release

From: Springer Nature

Investigating the potential effects of high protein intake

A high-protein diet and the resulting elevation in the amino acid leucine may contribute to atherosclerosis in mice, a study published in Nature Metabolism suggests. The paper, which also includes data from experiments in humans examining the effects of excess dietary proteins, provides insight into the potentially adverse effects of exceeding the recommended dietary protein intake.

While protein is a necessary macronutrient, people in Western societies consume around a third more protein than the recommended daily allowances on average. Previous research in animal models has linked excess protein to atherosclerosis (thickening and stiffening of arteries), and observational studies have associated excess protein with adverse cardiovascular events. However, current mechanistic studies investigating these relationships are limited.

Babak Razani and colleagues conducted two controlled experiments in humans using graded amounts of protein intake in a total of 23 male and female participants whose body mass index was classed as overweight. The first experiment involved 14 participants ingesting two 500-kilocalorie liquid meals, which on the first occasion was very high in protein and on the second was very low in protein. The second experiment involved 9 participants consuming a 450-kilocalorie standard meal on two occasions with either 16 grams of protein or 25 grams of protein. The authors took blood samples before and following both experiments at 1 and 3 hours after ingestion.

Based on these experiments, the authors suggest that dietary protein in excess of 25 grams per meal increases levels of the amino acid leucine in the circulation, which can affect monocytes and macrophages (cells that are part of the immune system). In subsequent cell based experiments the authors show that leucine is the predominant amino acid that can activate mTOR (which regulates many cell functions, such as proliferation, autophagy and apoptosis) in these cells. In a follow-up experiment in mice, the authors used three equivalent diets (high, moderate and low protein) and found that an ingestion of protein in excess of 22% of their dietary energy requirements also increased levels of leucine in circulation, affecting the immune cells and activating mTOR. The authors further show that increased levels of leucine are sufficient to promote atherosclerosis in male mice, even in the absence of high-protein diets. The authors suggest that their findings may have implications for understanding the effects of high-protein diets on cardiovascular events. However, they conclude that further research is needed to evaluate all the potential effects of differing protein intakes.

Journal/
conference:
Nature Metabolism
Research:Paper
Organisation/s: University of Pittsburgh School of Medicine and UPMC, USA
Funder: This work was supported by National Institutes of Health grants R01 HL125838 (to B.R.), R01 HL159461 (to B.R. and B.M.), R01 DK121560 (to B.M.), R01 DK131188 (to B.R., B.M. and J.D.S.), P30 DK056341 (Washington University Nutrition and Obesity Research Center), P30 DK020579 (Washington University Diabetes Research Center), UL1 TR000448 (Washington University School of Medicine Institute of Clinical and Translational Sciences) and T32 HL134635 (to A.R.) and grants from the US Department of Veterans Affairs MERIT I01 BX003415 (to B.R.), American Diabetes Association (1-18-IBS-029 to B.R.) and the Longer Life Foundation (to B.M.).
Media Contact/s
Contact details are only visible to registered journalists.